Sun Pharma Advanced Research Company Limited

NSE:SPARC.NS

207.44 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income -3,872.1-2,225.8-2,033.954-1,511.388-3,124.034-1,454.308-2,459.737-1,202.673-699.92-395.2343.242-224.947-722.321-84.997-215.438-124.913-45.615-18.343
Depreciation & Amortization 125.1117.7101.619109.23394.80575.52481.84682.39775.78672.39635.72333.95531.62329.85925.99118.36412.6741.004
Deferred Income Tax 000000000000000000
Stock Based Compensation 000000000000000000
Change In Working Capital -273.41,411.1-260.527-478.7631,020.166-1.705204.765133.242304.058-21.597.993-779.1027.11584.338302.65361.098-171.68815.475
Accounts Receivables 152.1-50.063-101.459-15.439-58.31174.041213.442-295.667107.57781.148-32.641-205.017000000
Inventory 00.0190000000000000000
Accounts Payables -58.9766.679-193.577-601.756717.751-194.01277.236356.857311.065000000000
Other Working Capital -366.6694.46534.509138.432360.726118.266-85.91367.458-114.584-91.231-42.324-540.213000000
Other Non Cash Items 93.15.8110.537361.962-98.991-338.659345.377-293.344-122.04-51.455-108.00316.655-10.902-4.15113.141-0.0060.7091.452
Operating Cash Flow -4,084.3-691.2-2,082.325-1,518.956-2,108.054-1,719.148-1,827.749-1,280.378-442.116-395.759368.955-953.439-694.48525.049126.344254.543-203.92-0.412
Investing Activities:
Investments In Property Plant And Equipment -265.1-153.9-326.779-59.951-540.427-129.519-326.302-85.796-123.283-80.949-36.74-36.029-45.122-47.341-81.834-262.349-45.0890
Acquisitions Net 4.923.4010.017-0.055540.42735.2149.47112.40112.35380.94936.7436.02945.1224.3800244.9290
Purchases Of Investments -250-10,552.3-47.758-0.05-1.047-1,188.838-5,663.169-435.126-234.788-386.664-5,952.399-1,800.92-340.165-111-40.854000
Sales Maturities Of Investments 4,201.85,2000.0527.3742,090.702261.3054,781.701342.395233.921452.246,901.261836.644354.06286.5520000
Other Investing Activites 0.001-0.00182.848.3-536.192-0.007161.5618.997-18.997448.489-512.918-28.778-38.139-8.1661.0031.450.9110.04
Investing Cash Flow 3,691.6-5,482.8-291.6715.6181,553.463-1,021.859-1,046.21-47.129-130.794514.065435.944-993.054-24.242-75.575-121.685-260.899200.7510.04
Financing Activities:
Debt Repayment -469.6-2,994.9-2,625.452-2,375.868-25.747-6.492-8.522-526.104-5.452-9.733-1,034.46-687.904-11.50-17.186000
Common Stock Issued 07,027.84,092.6002,749.9982,250.0012,481.12618.9970.2035.4391,865.33911000000
Common Stock Repurchased 0000-0.119-916.667000000000000
Dividends Paid 000000000000000000
Other Financing Activities -16.0362,134.7826.0613,968.711580.4841,832.301-1.329-31.513491.928-3.064220.664766.509622.54241.2219.97710.463-0.1350
Financing Cash Flow 440.26,167.62,293.2091,592.843554.6182,742.4732,240.151,923.509505.473-12.594-808.3571,943.944721.04241.222.79110.463-0.1350
Other Information:
Effect Of Forex Changes On Cash 0.020-0.0170.017000-0.1641.0960.5350.290.2490.06200000
Net Change In Cash 1,547.443-6.4-80.80389.5220.0271.466-633.809595.838-66.341106.247-3.168-2.32.377-9.3067.454.107-3.304-0.372
Cash At End Of Period 1,553.35.812.24293.0453.5233.4962.03635.83940.001106.3420.0953.435.733.35312.6595.227-3.1760.128